Abstract
Background
Recent evidence suggests that cardiac involvement in patients with granulomatosis with polyangiitis (GPA) occurs more frequently than previously reported. Multimodality cardiac imaging is gaining attention in the diagnosis, prognostication, and follow-up of such patients; however, the data remain scarce.
Results
2D-TTE was useful for initial screening; while both cardiac magnetic resonance imaging and 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18FDG-PET/CT) metabolic imaging with rubidium-82 PET perfusion imaging were useful for characterization of myocardial disease. 18FDG-PET/CT was very useful for the follow-up of cardiac disease activity following treatment.
Conclusion
18FDG-PET/CT is sensitive for the detection of cardiac involvement by GPA and is useful for the tissue characterization and follow-up of disease activity following treatment.
Similar content being viewed by others
Abbreviations
- c-ANCA:
-
c-Anti-neutrophil cytoplasmic antibody
- CMR:
-
Cardiac magnetic resonance
- 2D-TTE:
-
Two-dimensional transthoracic echocardiography
- 18FDG-PET/CT:
-
18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography
- GPA:
-
Granulomatosis with polyangiitis
- LGE:
-
Late gadolinium enhancement
- LV:
-
Left ventricle
- LVEF:
-
Left ventricular ejection fraction
- PET:
-
Positron emission tomography
- STIR:
-
T2-weighted short-tau inversion recovery
References
Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: a JACC White Paper. J Am Coll Cardiol. 2009;53(17):1475-87.
Yates M. Watts R. ANCA-associated vasculitis Clin Med (Lond). 2017;17(1):60-4.
Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54(8):1485-507.
Dilsizian V, Bacharach SL, Beanlands RS, Bergmann SR, Delbeke D, Dorbala S, et al. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures. J Nucl Cardiol. 2016;23(5):1187-226.
Silvera S, Palangié E, Guillevin L, Hendaoui L, Legmann P. Imaging features of granulomatosis with polyangiitis (Wegener’s). In: Hendaoui L, Stanson AW, Bouhaouala MH, Joffre F, editors. Systemic vasculitis imaging features. Springer Nature: Basel; 2018. p. 269-78.
Lutalo PM, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun. 2014;48-49:94-8.
Relle M, Fohr B, Fasola F, Schwarting A. Genetics and pathophysiology of granulomatosis with polyangiitis (GPA) and its main autoantigen proteinase 3. Mol Cell Probes. 2016;30(6):366-73.
Florian A, Slavich M, Blockmans D, Dymarkowski S, Bogaert J. Cardiac involvement in granulomatosis with polyangiitis (Wegener granulomatosis). Circulation. 2011;124(13):e342-4.
Saleh Farghaly HR, Alqarni AO, Nasr HA. 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in the Assessment of Occult Involvement in Widespread Granulomatosis with Polyangiitis (Wegener’s Granulomatosis). Indian J Nucl Med. 2019;34(2):153-6.
Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener’s granulomatosis and the heart. Br Heart J. 1994;71(1):82-6.
Pugnet G, Gouya H, Puechal X, Terrier B, Kahan A, Legmann P, et al. Cardiac involvement in granulomatosis with polyangiitis: a magnetic resonance imaging study of 31 consecutive patients. Rheumatology (Oxford). 2017;56(6):947-56.
Hazebroek MR, Kemna MJ, Schalla S, Sanders-van Wijk S, Gerretsen SC, Dennert R, et al. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis. Int J Cardiol. 2015;199:170-9.
Miszalski-Jamka T, Szczeklik W, Nycz K, Sokolowska B, Gorka J, Bury K, et al. Two-dimensional speckle-tracking echocardiography reveals systolic abnormalities in granulomatosis with polyangiitis (Wegener’s). Echocardiography. 2012;29(7):803-9.
McGeoch L, Carette S, Cuthbertson D, Hoffman GS, Khalidi N, Koening CL, et al. Cardiac Involvement in Granulomatosis with Polyangiitis. J Rheumatol. 2015;42(7):1209-12.
Walsh M, Flossmann O, Berden A, Westman K, Hoglund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64(2):542-8.
Guillevin L, Pagnoux C, Seror R, Mahr A, Mouthon L, Le Toumelin P, et al. The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore). 2011;90(1):19-27.
Al-Habbaa A, Rawla P, Morra ME, Abotaha AA, Sakr EE, Abdo Shehata MA, et al. Valvular involvement in granulomatosis with polyangiitis: Case report and systematic review of literature. Echocardiography. 2018;35(9):1456-63.
Lacoste C, Mansencal N, Ben M’rad M, Goulon-Goeau C, Cohen P, Guillevin L, et al. Valvular involvement in ANCA-associated systemic vasculitis: a case report and literature review. BMC Musculoskelet Disord. 2011;12:50.
Forstot JZ, Overlie PA, Neufeld GK, Harmon CE, Forstot SL. Cardiac complications of Wegener granulomatosis: a case report of complete heart block and review of the literature. Semin Arthritis Rheum. 1980;10(2):148-54.
Colin GC, Vancraeynest D, Hoton D, Jonard P, Gerber B. Complete heart block caused by diffuse pseudotumoral cardiac involvement in granulomatosis with polyangiitis. Circulation. 2015;132(17):e207-10.
Shakil O, Matyal R, Khabbaz K, Wang A, Mahmood F. Intracardiac Wegener’s granulomatosis. Ann Thorac Surg. 2012;94(4):e105.
Korantzopoulos P, Papaioannides D, Siogas K. The heart in Wegener’s granulomatosis. Cardiology. 2004;102(1):7-10.
Dewan R, Trejo Bittar HE, Lacomis J, Ocak I. Granulomatosis with Polyangiitis Presenting with Coronary Artery and Pericardial Involvement. Case Rep Radiol. 2015;2015:516437.
Subramanian HE, Sutaria R, Koumpouras F. The classification & diagnosis of granulomatosis with polyangiitis. The Rheumatologist. August, 2018.
Kane GC, Keogh KA. Involvement of the heart by small and medium vessel vasculitis. Curr Opin Rheumatol. 2009;21(1):29-34.
Oliveira GH, Seward JB, Tsang TS, Specks U. Echocardiographic findings in patients with Wegener granulomatosis. Mayo Clin Proc. 2005;80(11):1435-40.
Miszalski-Jamka T, Szczeklik W, Sokolowska B, Miszalski-Jamka K, Karwat K, Grzadziel G, et al. Cardiac involvement in Wegener’s granulomatosis resistant to induction therapy. Eur Radiol. 2011;21(11):2297-304.
Koldingsnes W, Nossent JC. Baseline features and initial treatment as predictors of remission and relapse in Wegener’s granulomatosis. J Rheumatol. 2003;30(1):80-8.
Hazebroek MR, van Paassen P, Dennert R, Heymans S. Chapter 20: ANCA-associated vasculitis: microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss Syndrome) and granulomatosis With polyangiitis (Wegener’s granulomatosis). In: The heart in rheumatic, autoimmune and inflammatory diseases. London: Academic Press; 2017. p. 459-502.
Zycinska K, Borowiec A, Zielonka TM, Rusinowicz T, Hadzik-Blaszczyk M, Cieplak M, et al. Echocardiographic Assessment in Patients with Granulomatosis with Polyangiitis. Adv Exp Med Biol. 2017;1022:27-33.
Ahn SS, Park ES, Jung SM, Song JJ, Park YB, Lee SW. Echocardiographic features in patients with ANCA-associated vasculitis within 3 months before and after diagnosis. Clin Rheumatol. 2017;36(12):2751-9.
Morelli S, Gurgo Di Castelmenardo AM, Conti F, Sgreccia A, Alessandri C, Bernardo ML, et al. Cardiac involvement in patients with Wegener’s granulomatosis. Rheumatol Int. 2000;19(6):209-12.
Goodfield NE, Bhandari S, Plant WD, Morley-Davies A, Sutherland GR. Cardiac involvement in Wegener’s granulomatosis. Br Heart J. 1995;73(2):110-5.
Guterbaum TJ, Husic M, Voss A, Dahl JS. Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis Causes Aortic Valve Degeneration and Severe Aortic Regurgitation. Am J Case Rep. 2019;20:423-9.
Taskesen T, Goldberg SL, Mannelli L, Rabkin D, Hawn TR, Fligner CL, et al. Granulomatosis With Polyangiitis Presenting With an Intracardiac Mass and Complete Heart Block: Enhanced Images by 3-Dimensional Echocardiography. Circulation. 2015;132(10):961-4.
Safak O, Gursul E, Polat M, Akcay F, Tuluce S, Aytemız F, et al. Wegener’s granulomatosis with cardiac involvement. International Journal of the Cardiovascular Academy. 2016;2(2):93-5.
Al-Mohaissen MA, Chan KL. Echocardiography in the Assessment of Patients with Rheumatologic Diseases. Curr Cardiol Rep. 2016;18(8):72.
Friedrich MG, Marcotte F. Cardiac magnetic resonance assessment of myocarditis. Circ Cardiovasc Imaging. 2013;6(5):833-9.
Mavrogeni S, Schwitter J, van Rossum A, Nijveldt R, Aletras A, Kolovou G, et al. Cardiac magnetic resonance imaging in myocardial inflammation in autoimmune rheumatic diseases: An appraisal of the diagnostic strengths and limitations of the Lake Louise criteria. Int J Cardiol. 2018;252:216-9.
Mavrogeni S, Markousis-Mavrogenis G, Koutsogeorgopoulou L, Dimitroulas T, Bratis K, Kitas GD, et al. Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naive patients with connective tissue diseases. Int J Cardiol. 2017;236:151-6.
Miszalski-Jamka T, Szczeklik W, Sokolowska B, Karwat K, Belzak K, Mazur W, et al. Standard and feature tracking magnetic resonance evidence of myocardial involvement in Churg-Strauss syndrome and granulomatosis with polyangiitis (Wegener’s) in patients with normal electrocardiograms and transthoracic echocardiography. Int J Cardiovasc Imaging. 2013;29(4):843-53.
Mavrogeni S, Manoussakis MN, Karagiorga TC, Douskou M, Panagiotakos D, Bournia V, et al. Detection of coronary artery lesions and myocardial necrosis by magnetic resonance in systemic necrotizing vasculitides. Arthritis Rheum. 2009;61(8):1121-9.
Both M, Ahmadi-Simab K, Reuter M, Dourvos O, Fritzer E, Ullrich S, et al. MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis. Ann Rheum Dis. 2008;67(7):1030-3.
Arlet JB, Le Thi Huong D, Marinho A, Cluzel P, Wechsler B, Piette JC. Arterial aneurysms in Wegener’s granulomatosis: case report and literature review. Semin Arthritis Rheum. 2008;37(4):265-8.
Amin S, Hossain R, Jeudy J, Frazier AA, White C. A Sensible Approach to Diagnosing Cardiac Aneurysms, Pseudoaneurysms and Common Mimickers. J Thorac Imaging. 2018;33(6):W39-47.
Paul M, Schafers M, Grude M, Reinke F, Juergens KU, Fischbach R, et al. Idiopathic left ventricular aneurysm and sudden cardiac death in young adults. Europace. 2006;8(8):607-12.
Hoey ET, Nagra I, Ganeshan A. Cardiac aneurysms and diverticula: magnetic resonance and computed tomography appearances. Curr Probl Diagn Radiol. 2011;40(2):72-84.
De Geeter F, Gykiere P. (18)F-FDG PET/CT imaging in granulomatosis with polyangiitis. Hell J Nucl Med. 2016;19(1):5-6.
Jiemy WF, Heeringa P, Kamps J, van der Laken CJ, Slart R, Brouwer E. Positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of macrophages in large vessel vasculitis: Current status and future prospects. Autoimmun Rev. 2018;17(7):715-26.
Hyafil F, Rischpler C, Nekolla S, Le Guludec D, Schwaiger M. Emerging clinical applications for PET/MR in the field of cardiovascular imaging. Médecine Nucléaire. 2016;40(1):11-9.
Lawal I, Sathekge M. F-18 FDG PET/CT imaging of cardiac and vascular inflammation and infection. Br Med Bull. 2016;120(1):55-74.
Slart RHJA, Writing group, Reviewer group, Members of EANM Cardiovascular, Members of EANM Infection & Inflammation, et al. FDG-PET/CT(A) imaging in large vessel vasculitis and polymyalgia rheumatica: joint procedural recommendation of the EANM, SNMMI, and the PET Interest Group (PIG), and endorsed by the ASNC. Eur J Nucl Med Mol Imaging. 2018;45(7):1250-69.
Elefante E, Bond M, Monti S, Lepri G, Cavallaro E, Felicetti M, et al. One year in review 2018: systemic vasculitis. Clin Exp Rheumatol. 2018;36(Suppl 111(2)):12-32.
Rischpler C, Woodard PK. PET/MR Imaging in Cardiovascular Imaging. PET Clin. 2019;14(2):233-44.
Osborne MT, Hulten EA, Murthy VL, Skali H, Taqueti VR, Dorbala S, et al. Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation. J Nucl Cardiol. 2017;24(1):86-99.
Bhambhvani P. Challenges of cardiac inflammation imaging with F-18 FDG positron emission tomography. J Nucl Cardiol. 2017;24(1):100-2.
Soussan M, Brillet PY, Nunes H, Pop G, Ouvrier MJ, Naggara N, et al. Clinical value of a high-fat and low-carbohydrate diet before FDG-PET/CT for evaluation of patients with suspected cardiac sarcoidosis. J Nucl Cardiol. 2013;20(1):120-7.
von Olshausen G, Hyafil F, Langwieser N, Laugwitz KL, Schwaiger M, Ibrahim T. Detection of acute inflammatory myocarditis in Epstein Barr virus infection using hybrid 18F-fluoro-deoxyglucose-positron emission tomography/magnetic resonance imaging. Circulation. 2014;130(11):925-6.
De Geeter F, Gykiere P. (18)F-FDG PET imaging of granulomatosis with polyangiitis -Wegener’s Syndrome. Hell J Nucl Med. 2016;19(1):53-6.
Kemna MJ, Vandergheynst F, Voo S, Blocklet D, Nguyen T, Timmermans SA, et al. Positron emission tomography scanning in anti-neutrophil cytoplasmic antibodies-associated vasculitis. Medicine (Baltimore). 2015;94(20):e747.
Ito K, Minamimoto R, Yamashita H, Morooka M, Okasaki M, Mimori A, et al. 18F-FDG PET/CT findings preceded elevation of serum proteinase 3 antineutrophil cytoplasmic antibodies in Wegener granulomatosis. Clin Nucl Med. 2014;39(1):e67-8.
Ito K, Minamimoto R, Yamashita H, Yoshida S, Morooka M, Okasaki M, et al. Evaluation of Wegener’s granulomatosis using 18F-fluorodeoxyglucose positron emission tomography/computed tomography. Ann Nucl Med. 2013;27(3):209-16.
Aydin M, Akkoyunlu ME, Yakar F, Ergul N, Sezer M. Intense FDG uptake on PET/CT in the upper and lower respiratory system indicative of Wegener’s granulomatosis. Rev Esp Med Nucl Imagen Mol. 2014;33(1):32-5.
Ozmen O, Tatci E, Gokcek A, Koksal D, Dadali Y, Ozaydin E, et al. Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener’s granulomatosis. Ann Nucl Med. 2013;27(10):907-15.
Soussan M, Abisror N, Abad S, Nunes H, Terrier B, Pop G, et al. FDG-PET/CT in patients with ANCA-associated vasculitis: case-series and literature review. Autoimmun Rev. 2014;13(2):125-31.
Ozdemir E, Yildirim-poyraz N, Senturk A, Uz E, Keskin M, Yüksel L, et al. 18F-FDG PET/CT Findings of a Patient with Wegener’s Granulomatosis Before and After Therapy. Molecular Imaging and Radionuclide Therapy. 2015;24(Supplement 1):1-3.
Scheel AK, Meller J, Vosshenrich R, Kohlhoff E, Siefker U, Muller GA, et al. Diagnosis and follow up of aortitis in the elderly. Ann Rheum Dis. 2004;63(11):1507-10.
Einspieler I, Thurmel K, Pyka T, Eiber M, Wolfram S, Moog P, et al. Imaging large vessel vasculitis with fully integrated PET/MRI: a pilot study. Eur J Nucl Med Mol Imaging. 2015;42(7):1012-24.
Bouhaouala MH, Hendaoui L, Stanson AW, Joffre F. Medical Imaging Investigation of Vasculitis. In: Stanson AW, Bouhaouala MH, Joffre F, editors. Hendaoui L. Systemic Vasculitis Imaging Features. Switzerland AG.: Springer Nature; 2018. p. 43-9.
Blockmans D, de Ceuninck L, Vanderschueren S, Knockaert D, Mortelmans L, Bobbaers H. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum. 2006;55(1):131-7.
Danve A, O’Dell J. The Role of 18F Fluorodeoxyglucose Positron Emission Tomography Scanning in the Diagnosis and Management of Systemic Vasculitis. Int J Rheum Dis. 2015;18(7):714-24.
Asawaeer M, Sayyed S, Chatzizisis YS. A rare case of granulomatosis with polyangiitis-induced burnout cardiomyopathy: role of combined viability and metabolic imaging. Eur Heart J Cardiovasc Imaging. 2018;19(5):584.
Mavrogeni SI, Sfikakis PP, Koutsogeorgopoulou L, Markousis-Mavrogenis G, Dimitroulas T, Kolovou G, et al. Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases. JACC Cardiovasc Imaging. 2017;10(11):1387-96.
Atzeni F, Corda M, Gianturco L, Porcu M, Sarzi-Puttini P, Turiel M. Cardiovascular Imaging Techniques in Systemic Rheumatic Diseases. Front Med (Lausanne). 2018;5:26.
Perel-Winkler A, Bokhari S, Perez-Recio T, Zartoshti A, Askanase A, Geraldino-Pardilla L. Myocarditis in systemic lupus erythematosus diagnosed by (18)F-fluorodeoxyglucose positron emission tomography. Lupus Sci Med. 2018;5(1):e000265.
Moncayo R, Kowald E, Schauer N, Pachinger O, Schmuth M, Fritsch P, et al. Detection of myocardial involvement in systemic lupus erythematosus: mismatch between normal perfusion scans with 201Thallium and pathological 18FDG uptake. International Angiology. 2001;20(4):314-21.
Acknowledgements
This work was funded by the Cardiovascular Disease in Women Research Chair at the Princess Nourah bint Abdulrahman University (Grant No. CDW-2019-02).
Disclosure
Rabah Al-Mehisen, Khalid Alnemri, and Maha Al-Mohaissen have no conflicts of interest to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Al-Mehisen, R., Alnemri, K. & Al-Mohaissen, M. Cardiac imaging of a patient with unusual presentation of granulomatosis with polyangiitis: A case report and review of the literature. J. Nucl. Cardiol. 28, 441–455 (2021). https://doi.org/10.1007/s12350-019-01809-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-019-01809-6